WallStreetZenWallStreetZen

NASDAQ: CRBP
Corbus Pharmaceuticals Holdings Inc Stock Ownership - Who owns Corbus Pharmaceuticals Holdings?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corbus Pharmaceuticals Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yong BenDirector2026-09-142,000$7.84
$15.68kSell
Nishant C. SaxenaCXO2026-08-112,600$9.63
$25.04kBuy
Sean F. MoranCFO2026-08-0712,000$10.08
$120.97kSell
Yuval CohenCEO2026-08-0717,000$10.08
$171.39kSell
John Kenneth JenkinsDirector2026-06-104,800$7.91
$37.99kSell
Anne AltmeyerDirector2026-06-102,412$7.91
$19.09kSell
Winston KungDirector2026-06-102,026$7.91
$16.03kSell
Nishant C. SaxenaChief Business Officer2026-06-039,000$7.58
$68.22kBuy
Nishant C. SaxenaChief Business Officer2026-06-024,500$7.33
$33.00kBuy
Dominic SmethurstChief Medical Officer2026-03-026,097$8.30
$50.60kSell

1 of 3

CRBP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRBP insiders and whales buy or sell their stock.

CRBP Shareholders

What type of owners hold Corbus Pharmaceuticals Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Cormorant Asset Management LP24.40%4,719,971$29.92MInsider
Sumner Burstein18.58%3,594,571$22.79MInsider
Knoll Capital Management LP14.22%2,750,000$17.44MInsider
Mark Tepper10.91%2,110,400$13.38MInsider
David P. Hochman4.23%818,700$5.19MInsider
Barbara White1.07%206,217$1.31MInsider
Yuval Cohen0.81%157,316$997.38kInsider
Dominic Smethurst0.46%89,790$569.27kInsider
Sean F. Moran0.44%84,694$536.96kInsider
Nishant C. Saxena0.40%77,900$493.89kInsider

1 of 3

CRBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRBP0.07%76.94%Net SellingNet Selling
UNCY0.04%16.43%
INO0.03%30.13%Net Selling
FHTX0.08%14.30%
VTVT0.00%100.00%
View Top Biotech Stocks

Corbus Pharmaceuticals Holdings Stock Ownership FAQ

Who owns Corbus Pharmaceuticals Holdings?

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) is owned by 0.07% institutional shareholders, 76.94% Corbus Pharmaceuticals Holdings insiders, and 22.99% retail investors. Cormorant Asset Management LP is the largest individual Corbus Pharmaceuticals Holdings shareholder, owning 4.72M shares representing 24.40% of the company. Cormorant Asset Management LP's Corbus Pharmaceuticals Holdings shares are currently valued at $28.93M.

If you're new to stock investing, here's how to buy Corbus Pharmaceuticals Holdings stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.